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Senescence is a form of cell-cycle arrest linked to
tumor suppression and aging. However, it remains
controversial and has not been documented in
nonpathologic states. Here we describe senescence
as a normal developmental mechanism found
throughout the embryo, including the apical ecto-
dermal ridge (AER) and the neural roof plate, two
signaling centers in embryonic patterning. Embry-
onic senescent cells are nonproliferative and share
features with oncogene-induced senescence (OIS),
including expression of p21, p15, and mediators of
the senescence-associated secretory phenotype
(SASP). Interestingly, mice deficient in p21 have
defects in embryonic senescence, AER mainte-
nance, and patterning. Surprisingly, the underlying
mesenchyme was identified as a source for senes-
cence instruction in the AER, whereas the ultimate
fate of these senescent cells is apoptosis and
macrophage-mediated clearance. We propose that
senescence is a normal programmed mechanism
that plays instructive roles in development, and that
OIS is an evolutionarily adapted reactivation of a
developmental process.INTRODUCTION
Senescence is a form of cell-cycle arrest first identified in cells at
the end of their replicative lifespan (Hayflick, 1965). Subse-
quently, it was demonstrated that senescence could be induced
prematurely by oncogenes in primary cells, inducing oncogene-
induced senescence (OIS) (Serrano et al., 1997). This was
followed by the discovery in adult cells of other senescence-
inducing stimuli, including DNA damage, oxidative stress, and
chemotherapeutic drugs (Kuilman et al., 2010; Narita et al.,
2003; Schmitt et al., 2002).
Senescent cells usually share a combination of signature fea-
tures, including a characteristic, enlarged, and flat morphology.CPrimarily, they are nonproliferating, exhibit activation of senes-
cence-associated beta-galactosidase (SAb-gal) activity, and
have enhanced expression of hallmark regulatory proteins (Dimri
et al., 1995; Kuilman et al., 2010). Among the key proteins that
are induced are members of the p53/p21 and p16/RB tumor-
suppressor networks that function to arrest proliferation and
contribute to the irreversibility of the senescent state (Narita
et al., 2003; Serrano et al., 1997). This involvement of tumor-
suppressor pathways led to the identification of senescence as
a potent tumor-suppressor mechanism in vivo (Braig et al.,
2005; Chen et al., 2005; Collado et al., 2005; Michaloglou
et al., 2005). More recently, however, broader roles for senes-
cence in nontumorigenic pathologies are emerging. Senescent
cells are suggested to increase in number with age and to
contribute significantly to age-related decline (Baker et al.,
2011; Dimri et al., 1995). Senescent cells also contribute to the
process of liver fibrosis and wound repair (Jun and Lau, 2010;
Krizhanovsky et al., 2008). However, to date, senescence has
not been described in nonpathologic states.
An emerging hallmark feature of senescent cells is the
senescence-associated secretory phenotype (SASP) that allows
extensive signaling from the nonproliferating cells to the external
environment (Acosta et al., 2008; Coppe´ et al., 2010; Kuilman
et al., 2008, 2010). This secretome is largely composed of growth
factors, cytokines/chemokines, and extracellular-matrix-remod-
eling proteins secreted by the arrested cells (Freund et al., 2010).
Some of these secreted factors have functional roles compatible
with senescence, such as the reinforcement of the arrested state
(Acosta et al., 2008; Kuilman et al., 2008) or the recruitment of
immune cells to remove senescent cells (Xue et al., 2007). How-
ever, there are paradoxical aspects of the SASP and senescence
that argue against a sole tumor-suppressive role. In some
instances, the SASP can induce proliferation or epithelial-to-
mesenchymal transformation (EMT) and invasion in neighboring
cells, exerting protumorigenic influence (Krtolica et al., 2001;
Parrinello et al., 2005). In others, senescent cells instruct angio-
genesis and vessel patterning (Coppe´ et al., 2006) or alter the
local environment with the production of matrix-remodeling
factors (Coppe´ et al., 2008; Parrinello et al., 2005). In addition,
senescent cells are resistant to apoptotic stimuli, a finding at
odds with their tumor-suppressive role (Mooi and Peeper,
2006; Wang, 1995).ell 155, 1119–1130, November 21, 2013 ª2013 Elsevier Inc. 1119
Figure 1. Senescence-Associated b-Galactosidase Is Expressed in
Many Tissues during Embryonic Development
Mouse and chick embryoswere stained at thewhole-embryo level for SAb-gal.
Representative images of regions that stained positive are shown.
(A) Mouse embryo, E11.5.
(B) mouse hindlimb, E11.5.
(C) The distal tip of the mouse tail, E14.5.
(D) Mouse otic vesicle, E10.5.
(E) Fusion zone of the vesicles of the mouse hindbrain, E11.5.
(F) Fusing neural tube of the mouse, E11.5.
(G) Chick pharyngeal arches, Hamburger and Hamilton (HH) stage 28.
(H) Chick neural tube, HH28. Arrows denote the line of positive staining along
the length of the neural tube.
(I) Chick eye, HH28.
Total numbers examined at each stage listed in Table S1. OV: otic vesicle, HL:
hindlimb, FL: forelimb, LH: left hemisphere, RH: right hemisphere, NT: neural
tube, PA: pharyngeal arch. See also Figure S1 and Table S1.In many ways, as a distinct cellular process, senescence can
be equated to apoptosis, a tumor-suppressive mechanism that
acts to functionally remove cells at risk of aberrant growth. In
addition, both processes have demonstrated roles in tissue1120 Cell 155, 1119–1130, November 21, 2013 ª2013 Elsevier Inc.pathology and repair. Given that apoptosis also has critical func-
tions during normal embryonic development, we asked whether
senescence might also play a role in the embryo. Surprisingly,
we found that senescent cells are detectable in many different
tissues and locations throughout the embryo, including known
signaling centers. We describe that senescence is a normal pro-
grammed component of embryonic development and uncover a
role in tissue development and patterning.
RESULTS
Senescent Cells Are Widespread throughout the
Developing Embryo
To investigate whether senescence is expressed in the devel-
oping embryo, we used whole-mount staining for SAb-gal
activity. We had previously demonstrated that this approach
identifies senescent cells in amodel where senescencewas acti-
vated prematurely (Keyes et al., 2005). Embryos at mid to late
stages of development (embryonic days [E] 9.5–17.5) were
stained with SAb-gal and were examined for the appearance of
positively staining cells. Surprisingly, distinct regions were
immediately visible (Figure 1), and it was clear these were spe-
cific anatomical structures and locations throughout the embryo.
Examples of positive areas included the developing limbs (Fig-
ures 1A and 1B), the tip of the tail (Figure 1C), the otic vesicle (Fig-
ure 1D), the brain vesicles (Figure 1E), the closing neural tube
(Figure 1F), the fusing sternum midline, and the gut endoderm
(Table S1 and Figure S1A available online). Sectioning of these
embryos that had been stained with SAb-gal further identified
specific stained populations of cells and tissues (Figure S1A).
Interestingly, the staining in each location was detectable in
100% of animals but was only detectable during a specific
time window, with all senescence detectable in this manner dis-
appearing by E17.5 (sites and timeline are detailed in Table S1).
Staining with SAb-gal identifies senescent cells at acidic pH 5.5.
To support that the staining in the embryo indicated senescence,
we stained embryos at pH 6.5 and 7.0. In each case, no staining
was detectable, validating the senescent phenotype of the pos-
itive cells (Figure S1B). To further investigate these findings, we
tested to see whether SAb-gal was detectable in chick embryos.
Interestingly, similar distinct patterns of staining were visible
throughout the embryo, including at the limbs, in the pharyngeal
arches (Figure 1G), along the closed neural tube/spinal column
(Figure 1H), and in the developing eye (Figure 1I). Together,
this identifies that SAb-gal staining is found in distinct structures
and tissues during particular time windows in the normal
developing embryo.
Embryonic Structures Express Molecular Mediators
of Senescence
To verify that SAb-gal indicated senescence, we examined for
expression of known markers and mediators of senescence in
two separate tissues that presented with pronounced SAb-gal
at E11.5. Senescence in the limb appeared as a distinct layer
around the edge of the developing limb bud in a pattern reminis-
cent of the apical ectodermal ridge (AER) (Figure 2A). The AER is
a zone of specialized ectodermmarking the dorsoventral bound-
ary of the limb bud and is amajor signaling center regulating limb
Figure 2. Senescence Markers Are Ex-
pressed in the Developing Forelimb and
Neural Tube
(A) Forelimb stained for SAb-gal, BrdU incorpora-
tion, p53, and p21 by immunohistochemistry. The
insert panel of positive p53 staining corresponds
to limb mesenchymal tissue of irradiated wild-type
(WT) embryos. Top left image shows SAb-gal
whole-mount staining with a line showing the plane
of section for the staining. Bottom left image was
processed for in situ hybridization with FGF8 and
scanned by OPT to allow visualization of the AER.
The graphs at the bottom show the percentage of
positively stained cells in the AER and underlying
mesenchyme (mes).
(B) Left panels show whole-mount embryo high-
lighting plane of section, and below, box indicates
area shown in high-magnification images. Neural
tube stained for SAb-gal, BrdU incorporation, p53,
and p21 by immunohistochemistry. The BrdU
insert corresponds to an enlarged area in the
neural tube. The graphs at the bottom show the
percentage of positively stained cells in the neural
RP and adjacent mesenchyme (mes).
All samples stained were WT embryos at E11.5.
Values are expressed as mean ± SEM; n = total
number of embryos analyzed. See also Figure S2.outgrowth and patterning (Cohn et al., 1995; Niswander et al.,
1993). It lies directly above and, via secreted growth factors
including fibroblast growth factors (FGFs), instructs the progress
zone (PZ), an area of mesenchymal proliferation at the tip of the
limb. In turn, the PZ is reciprocally required to maintain AER
function (Kanegae et al., 1998). The AER can be identified with
in situ hybridization for FGF8, which develops in a pattern of
expression that exactly matches that of SAb-gal (Figure 2A).
Sectioning of the whole-mount SAb-gal-stained embryos
confirmed that the AER stains positive for senescence. Next,
we tested for the expression of known senescence markers,
including p53, p21, p16, p19, PML, gH2AX, and H3K9me3, as
well as the ability to incorporate BrdU. Interestingly the cells
of the AER were nonproliferative and expressed high levels of
p21, but not p53 (Figure 2A), whereas the adjacent zone of
proliferative mesenchyme was negative for these senescenceCell 155, 1119–1130, Nomarkers. In addition, the AER expressed
PML and H3K9me3 (Figure S2A) but at
levels similar to the those of proliferating
mesenchymal cells, whereas p16 (not
shown) and p19 expression were not
detectable in the limb.
To identify whether similar results were
seen in other regions of the embryo, we
looked at the closing neural tube, where
a line of senescent cells was visible (Fig-
ures 1F and 2B). Transverse sections of
SAb-gal-stained E11.5 embryos identi-
fied a narrow band of epithelial cells, the
roof plate (RP) of the hindbrain, that
were stained with SAb-gal (Figure 2B).
The RP is another signaling center thatinstructs central nervous system (CNS) cell fate, induces neural
crest activity, and contributes to blood vessel patterning along
the embryonic axis (Chizhikov and Millen, 2004; Gammill and
Bronner-Fraser, 2003; Lee et al., 2000). Analysis of senescence
markers confirmed that these cells are also nonproliferative and
express high levels of p21 but do not have detectable levels of
p53, p16 (not shown), or p19 (Figures 2B and S2B). Interestingly,
in the chick, this structure expresses the transcript for p15,
another key regulator of senescence (Kim et al., 2006). Together,
this identifies that two major signaling centers in the embryo
contain senescent cells.
The AER Shares an Expression Signature with OIS
We wanted to assess whether these structures expressed any
other markers of senescence or shared similarity with OIS. As
a first step, we performed gene-expression profiling on thevember 21, 2013 ª2013 Elsevier Inc. 1121
Figure 3. Developmental Senescence
Shares a Molecular Signature with OIS
(A) Schematic demonstrating regions in which
tissue samples were collected for microarray
(red = AER, and green = ectoderm). Representa-
tive heatmap of the microarray profile on AER
compared to nonsenescent adjacent ectoderm is
shown. Example genes are shown to demonstrate
that known markers of the AER were expressed at
higher levels (red) in the AER compared to the
ectoderm (green) (left). qPCR expression on
separate biological replicates for FGF8 and FGF4
is shown. Values are expressed as mean ± SEM.
(B) Representational overlap of the microarray
profile of gene probes that were upregulated >1.4-
fold in the AER versus ectoderm compared to
those that were upregulated >1.4-fold in two
pooled arrays of IMR90 human fibroblasts under-
going OIS. Statistical analysis denotes Fisher’s
test of enrichment, p = 0.029. OIS data are from
Collado et al., 2005. Representative examples of
genes from each section are denoted with arrows.
The full list of genes and their overlap is shown in
Table S2, along with the AER expression values for
the genes common to OIS and AER. Underlying
graphs represent GO analysis of upregulated
genes common to senescence and development
(left), downregulated genes (Figure S3), and genes
in OIS (right).
(C) qPCR validation on separate biological
replicates for selected genes identified in the
microarray. Values are expressed as mean ± SEM.
Ecto, Ectoderm; AER, apical ectodermal ridge.
See also Figure S3 and Table S2.AER. The AER was microdissected from E11.5 mouse forelimbs,
and pooled replicates were compared to samples of nonsenes-
cent surface ectoderm from the dorsal-proximal limb bud (Fig-
ure 3A). Importantly, many known AER genes, including FGF8
and 4, Msh homeobox (MSX) 1 and 2, distal-less homeobox1122 Cell 155, 1119–1130, November 21, 2013 ª2013 Elsevier Inc.(DLX) 1 and 2, and R-Spondin 2
(RSPO2), were among the most highly
detected (Figure 3A), validating that this
is an AER-enriched gene-expression
profile. We used real-time quantitative
polymerase chain reaction (qPCR) for
FGF8 and FGF4 genes to validate these
results on separate biological samples
(Figure 3A).
Next, we used published data sets to
retrieve gene-expression signatures of
senescent cells. Collado et al. (2005;
GEO accession number GSE2487) pro-
filed senescent IMR90 human fibroblasts
induced into OIS (Collado et al., 2005).
This study provides two separate profiles
of senescent cells, which we merged to
extract a representative gene-expression
signature of senescence induced by
oncogenic stimulation. This was then
overlapped with the signature of theAER-enriched genes to identify those unique to each state and
those genes common to both the AER and OIS (Figure 3B and
Table S2). Surprisingly, from 546 AER-enriched genes that
were common to both studies, 50% (271 genes; p = 0.029;
Fishers enrichment test) exhibited increased expression in
senescent human fibroblasts (Figure 3B and Table S2), whereas
60% (273 genes; p = 0.0004; Fishers enrichment test) of the
downregulated genes also overlapped (Figure S3A).
Interestingly, among the upregulated genes common to both
senescent human fibroblasts and the AER were the senescence
inducers p21 (CDKN1A) and p15 (CDKN2B) (Figure 3B). How-
ever, many other genes that were previously implicated in the
regulation of senescence and the SASP, such as CCAAT/
enhancer-binding protein beta (CEBP/B), insulin-like growth
factor-binding protein 5 (IGFBP5), wingless-type MMTV integra-
tion site family, member 5A (WNT5A), and the macrophage-
recruiting factors colony-stimulating factor 1 (CSF1) and CD44,
were also increased in the AER. Gene Ontology (GO) analysis
of the signature common to the AER and OIS highlights the
developmental profile of the genes that are up- and downregu-
lated (Figures 3B and S3). The increased expression in the
AER for a number of these common genes was confirmed by
qPCR on separate biological samples (Figure 3C). In addition,
we used the embryonic midline, another site of in vivo senes-
cence, to validate expression of some senescence markers.
Interestingly, in this tissue, p15 was also prominently expressed
(Figure S3B), suggesting that it might be a common regulator of
developmental senescence.
Furthermore, among the genes thatwere expressed in the AER
but did not overlapwith this profile of OISwere othermediators of
senescence, including Retinoblastoma (RB1), B-Raf protoonco-
gene serine/threonine-protein kinase (BRAF), checkpoint kinase
2 (CHEK2), and activating transcription factor 2 (ATF2) (Fig-
ure 3B). Together, this identifies that the AER shares a significant
gene-expression signature with OIS, in particular expressing
critical mediators of the senescence program and the SASP.
However, it was striking to also note that in OIS, there was a
strong expression of genes that comprise many well-known
developmental pathways (Figure 3B). Indeed, we used GO anal-
ysis on the OIS signature to identify biological processes that are
altered in senescent cells. Surprisingly, this identified that many
developmental processes are among the main signatures and
pathways of the genes that change expression (Figure 3B).
This identifies that the induction of OIS involves changes in
expression of many different developmental pathways.
p21-Deficient Mice Exhibit Alterations in Senescence
and Limb Patterning
As a first step toward identifying a possible role for senescence
in the embryo, we examined mouse models that are genetically
deficient in known senescencemediators. We identified p21 as a
common marker of senescent cells in the developing embryo
and OIS. Although mice deficient in p21 are described as being
developmentally normal (Brugarolas et al., 1995; Deng et al.,
1995), we sought to examine this more closely and assess
whether p21 deficiency might cause defects in embryonic
senescence. Initially, we subjected p21-deficient mice at E11.5
to whole-embryo SAb-gal staining. Interestingly, we noticed
that these mice had a significant reduction in the total number
of SAb-gal-positive cells in the AER (Figure 4A). In addition to
inhibiting the cell cycle, a major function of p21 is to prevent
apoptosis. To identify the impact of p21 deficiency and impaired
senescence, we looked for changes in proliferation or cell death.CSurprisingly, we found a significant increase in cell death in the
SAb-gal-positive cells of the AER as measured by TUNEL stain-
ing (Figure 4B), suggesting that in the absence of p21, these cells
adopted a fate of cell death. Interestingly, there was no differ-
ence in the rate of proliferation in the AER in the absence of
p21 (Figure 4C). However, there was a significant decrease in
proliferation in the mesenchyme directly below the AER, sug-
gesting that the function of the AER in promoting proliferation
in the underlying tissue was impaired as a result of impaired
senescence (Figure 4C, right graph).
Toextend this analysis and todeterminewhether lossof senes-
cence in p21-deficientmicemight affect the integrity and function
of the AER, we assayed for FGF expression. Interestingly, in the
AER, these mice exhibited decreased expression of FGF8 and
FGF4, two key proliferation-inducing signals from the AER to
the mesenchyme and limb (Figure 4D) (Capdevila and Izpisu´a
Belmonte, 2001; Sun et al., 2002). This suggests that the function
of the AER in instructing pattern formation and proliferation to the
mesenchyme might be compromised in p21-deficient animals.
To evaluate this, we dissected the PZ from limbs at E11.5 and
performed qPCR for known patterning genes (Figure 4E). Inter-
estingly, p21-deficient mice had a significant disruption of the
normal pattern for many of these genes, including GLI3, MSX2,
MEIS1, and SHH, and a decrease in the proliferation marker
KI67 (Figure 4E; unmerged graphs of biological replicates in
Figure S4). Together, these data demonstrate that p21 is required
for normal senescence and patterning in the limb.
Interestingly, p21 directly regulates the expression of some
SASP components (Chang et al., 2000; Devgan et al., 2006).
To ask whether p21 might also regulate developmental
patterning genes in OIS, we used the tissue culture model of
OIS induced in IMR90 human fibroblasts. In these cells, we
used small interfering RNA (siRNA) to knock down p21 levels in
senescent cells and, as proof-of-principle, assayed for the
expression of some of the developmental patterning genes
that were identified in OIS (Figures 4F and S4C). Interestingly,
we found that a deficiency of p21 directly in senescent cells
significantly disrupted the pattern of expression of select devel-
opmental mediators. Together, this suggests that p21 is a critical
mediator of developmental senescence, and that these func-
tions might be partially conserved in OIS.
Senescence Overlaps with the Pattern of the AER
In the embryo, we identified that developmental senescence
appears during particular time windows but disappears before
birth. To identify the ultimate fate of embryonic senescent cells,
we performed a time-course staining on the limb. During devel-
opment, the limb bud develops from reciprocal signaling
between the ectoderm and underlying mesenchyme to initiate
outgrowth at E9.5 (Capdevila and Izpisu´a Belmonte, 2001).
Limb development proceeds through well-defined stages to
reach the state of a mature appendage by E17.5. We examined
the developing limb for SAb-gal staining at each stage. Staining
was visible in the distal tip of the initiating limb bud at E9.5 (Fig-
ure 5A). By E10.5–11.5, the pattern of senescence became
restricted to the tip of the limb in the developing AER (Figures
5B and 5C). The AER is a transient structure that persists until
later stages of development, before ingressing into theell 155, 1119–1130, November 21, 2013 ª2013 Elsevier Inc. 1123
Figure 4. p21 Deficiency Impairs Develop-
mental Senescence and Induces Patterning
Defects in Limbs and OIS Cells
(A) Representative images of limbs from WT and
p21-deficient embryos that had been stained at
the whole-embryo level for SAb-gal at E11.5 and
corresponding sections. Graph shows percentage
of SAb-gal-positive cells in the AER in WT and
p21-deficient embryos (n = 7 embryos; values
are ± SEM, t test).
(B) Sections of whole-mount stained SAb-gal
embryos, costained with TUNEL. Graph shows
percentage of the SAb-gal population that are
TUNEL positive in the AER inWT and p21-deficient
embryos (n = 5 embryos; values are ± SEM, t test).
(C) Graphs shows the percentage of BrdU
incorporation in the AER and mesenchyme in WT
and p21-deficient embryos (n = 5 embryos; values
are ± SEM, t test).
(D) In situ hybridization for FGF8 on forelimbs and
hindlimbs of WT and p21-deficient mice at E11.5.
qPCR for FGF4 expression in the AER from WT
and p21-deficient embryos is shown (n = 5
embryos; values are ± SEM, t test).
(E) The anterior limbs of WT and p21-deficient
embryos were removed at E11.5, and qPCR was
performed for representative genes involved in
limb patterning (n = 4 embryos; values are ± SEM,
t test).
(F) Growing IMR90 cells (black columns; Vec:
vector) or Ras-infected senescent IMR90 cells
(gray columns; RasV12) were infected with control
siRNA (c) or an siRNA targeting p21 (p21) and were
assayed by qPCR for the indicated genes (values
are ± SEM, Anova and t tests).
See also Figure S4.interdigital spaces (Guo et al., 2003). Interestingly, the pattern of
staining with SAb-gal seemed to very closely follow that of the
AER, with staining persisting through E12.5 and E13.5 (Figures
5D and 5E). By E13.5, senescent cells were apparent in the
developing interdigital spaces, and by E14.5, following disap-
pearance of most of the interdigital tissue, senescence staining
was prominent on the posterior flanks of the digits (Figure 5F).
By E15.5, staining had virtually disappeared, with only small
focal regions remaining on the tips of the developing nails (Fig-
ure 5G), and was no longer detectable by E16.5–17.5 (Figures1124 Cell 155, 1119–1130, November 21, 2013 ª2013 Elsevier Inc.5H and 5I). In addition, a similar pattern
of expression and timing was seen in the
AER of developing chick wing bud (Fig-
ure S5). Altogether, this demonstrates
that senescent cells and the AER follow
the same pattern and distribution during
a precise developmental window.
Senescent Cells in the Limb Are
Removed by Apoptosis and
Immune-Mediated Clearance
In stress-induced senescence, senescent
cells are removed by immune-mediated
clearance (Kang et al., 2011; Xue et al.,2007). In the embryo, the AER is removed by apoptosis and
macrophage-mediated phagocytosis (Guo et al., 2003; Wood
et al., 2000). To uncover the cause of senescence disappearance
in the limb, we sectioned limbs from embryos at E11.5–14.5 that
had been whole-mount stained for SAb-gal. At the histological
level, the redistribution of the pattern of senescent cells was
clearly visible. At E11.5–12.5, senescent cells were largely
detectable in the ectoderm of the AER (Figures 6A, 6B, and
6E). However, by E13.5, there were fewer positive cells in the
surface ectoderm/AER, and the remaining senescent cells
Figure 5. Timeline of Senescence during Mouse Forelimb
Development
SAb-gal staining showing the localization of senescent cells during mouse
forelimb development. (A) E9.5; (B) E10.5; (C) E11.5, showing prominent
staining in the AER; (D) E12.5; (E) E13.5; (F) E14.5; (G) E15.5; (H) E16.5; (I)
E17.5. See also Figure S5.were predominantly detected in the adjacent mesenchyme (Fig-
ures 6C and 6E). By E14.5, senescent cells had practically disap-
peared from the digit ectoderm (Figures 6D and 6E), and the
remaining cells were predominantly in the posterior mesen-
chyme. Interestingly, once senescent cells appeared in the
mesenchyme, they were frequently surrounded by clusters of
immune cells (Figures 6C and 6D, II0–III0). Immunostaining for
the macrophage marker F4/80 revealed that, consistent withCprevious reports (Wood et al., 2000), there is an infiltration of
macrophages in the developing limb, and that by E13.5–14.5,
these are predominantly located in the mesenchyme surround-
ing the senescent cells, suggesting that developmental senes-
cent cells might also be removed by macrophage-mediated
clearance (Figure S6).
Next, we costained SAb-gal sections with TUNEL to identify
whether these cells might be undergoing apoptosis. At E11.5–
12.5, only a small percentage of the senescent cells in the AER
were apoptotic (Figures 6A, 6B, and 6E). By E13.5 however,
this percentage increased in both the ectoderm and the mesen-
chyme (Figures 6C and 6E), and by E14.5, almost all of the
remaining senescent cells, now located in the interdigital mesen-
chyme, were apoptotic (Figures 6D and 6E). Interestingly, the
clusters of immune cells surrounding the senescent cells also
stained positive for TUNEL, presumably identifying macro-
phages containing apoptotic bodies (Figures 6C and 6D). At
each stage, the number of apoptotic cells outnumbered the
quantity of dying senescent cells, suggesting that there are
separate populations of cells undergoing apoptosis at this stage.
Altogether, this identifies that, at least in the AER, senescent
cells undergo a coordinated process of redistribution to the
interdigital mesenchyme, apoptosis, andmacrophage-mediated
clearance.
Senescence in the AER Is Instructed by Paracrine
Signaling from the Underlying Stroma
The AER initiates through instructive signaling from the
underlying mesenchyme. In turn, the established AER instructs
proliferation through growth factor signaling, which activates
phospho-ERK (pERK) pathways in the mesenchyme (Corson
et al., 2003). Reciprocally, the mesenchyme then maintains
AER function, establishing interdependency of the two regions
(Capdevila and Izpisu´a Belmonte, 2001; Kanegae et al., 1998).
Surprisingly, adult stress-induced senescence is maintained in
part by ERK signaling, with these growth-promoting signals
paradoxically contributing to the arrested state. Given that
senescence is synonymous with the AER, we asked whether it
too might be mediated by signals arising from the mesenchyme.
First, we determined pERK expression in the whole limb at
E11.5, specifically detecting pERK only in the mesenchyme un-
derlying the AER (Figure 7A) as previously demonstrated (Corson
et al., 2003). Next, we wanted to determine whether transient
in vivo inhibition of ERK signaling could affect senescence. To
address this, we injected pregnant females at E11.5 with the
MEK inhibitor U0126, which prevents ERK phosphorylation
in vivo and blocks OIS in the adult (Shukla et al., 2007). Surpris-
ingly, this led to a significant reduction of the number of
senescent cells in the AER (Figure 7B), suggesting that pERK-
mediated signaling in the mesenchyme establishes paracrine
instruction of senescence in the AER. Next, to see whether pro-
longed inhibition of ERK signaling might have additional effects,
we cultured E11.5 embryonic limbs for 15–24 hr in the presence
of U0126 (Figure 7C). Remarkably, while control limbs developed
normally and retained a normal pattern of senescence, inhibition
of ERK signaling led to a significant loss of senescence in the
AER concomitant with abnormal development of the limb.
Together, this suggests that senescence is maintained in partell 155, 1119–1130, November 21, 2013 ª2013 Elsevier Inc. 1125
Figure 6. Senescent Cells in the AER Are
Removed by Apoptosis and Immune-
Mediated Clearance
Representative OPT scans of whole limbs at each
stage are shown to illustrate plane of section.
(A) E11.5 SAb-gal-stained forelimb and TUNEL
overlap.
(B) E12.5.
(C) E13.5. Bars I, II, and II denote plane of section in
images, and highermagnification of boxed areas is
shown in I0, II0, and III0. Note that senescent cells
are surrounded by clusters of immune cells in II0
and III0.
(D) E14.5, similar notation of plane of section and
high-magnification images as seen in (C). Inset in
II0 shows clusters of immune cells surrounding a
senescent cell.
(E) Shown are the numbers of SAb-gal-positive
cells in the ectoderm and mesenchyme at each
stage (left) and the percentages of the total
SAb-gal cells that are TUNEL positive at each
stage in the ectoderm and in the mesenchyme
(right) (values are ± SEM).
See also Figure S6.via paracrine signals from the underlying mesenchyme, and
that a deregulation of this process leads to developmental
abnormalities.
DISCUSSION
Here we describe that senescence is a key feature of embryonic
development and, importantly, identify senescent cells in a1126 Cell 155, 1119–1130, November 21, 2013 ª2013 Elsevier Inc.normal in vivo setting. We use chick and
mouse models to show that senescence
is a recurrent process in the embryo,
is restricted to particular regions and
structures, and follows a specific time
course, identifying that developmental
senescence is a conserved programmed
mechanism.
We used SAb-gal staining to identify
senescent cells in the embryo because it
is a proven and reliable marker of senes-
cence in vivo in many settings, including
premalignant lesions (Chen et al., 2005;
Collado et al., 2005; Michaloglou et al.,
2005), chemotherapy and tumor regres-
sion (Schmitt et al., 2002; Xue et al.,
2007), premature aging (Baker et al.,
2011; Keyes et al., 2005), fibrotic tissue
(Jun and Lau, 2010; Krizhanovsky et al.,
2008), and aging human skin (Dimri
et al., 1995). Furthermore, in addition to
the many regions identified here with
a whole-mount staining approach, we
believe that many other developing struc-
tures will also use senescence to mediate
correct patterning at distinct stages ofdevelopment, as exemplified in the accompanying manuscript
(Mun˜oz-Espı´n et al., 2013).
Interestingly, we identified significant overlap between devel-
opmental and oncogene-induced senescence, including
expression of p21, p15, and a number of SASP components
(Kuilman et al., 2010). Subsequently, to characterize develop-
mental senescence, we focused on the AER and the RP.
Interestingly, these are both major signaling centers in the
Figure 7. Instructive Signals from the
Stroma Maintain Senescence in the AER
(A) Immunofluorescence of pErk showing locali-
zation in the mesenchyme in E11.5 forelimbs.
(B) Inhibition of pErk in vivo leads to a decrease
in senescence in the AER. Quantification of
percentage of SAb-gal-positive cells in control
(DMSO) and U0126-treated embryos (n = 5
embryos, values are ± SEM, t test).
(C) Inhibition of pErk in cultured limbs shows
a partial loss of senescence in the AER and
abnormal patterning. Western blot shows a loss of
pErk in cultured limbs.
(D) Model demonstrating proposed function of
p21-mediated senescence in the AER: inducing
senescence during development, protecting from
apoptosis, and instructing local tissue patterning,
which is in part maintained by pErk-mediated
signals from the mesenchyme.embryo that instruct growth and patterning through the release
of secreted factors and whose disruption can significantly per-
turb normal development (Chizhikov and Millen, 2004; Lee
et al., 2000; Mariani et al., 2008). Remarkably, in each case,
the secreted proteins are common components of the SASP of
adult stress-induced senescence, suggesting that some of the
paradoxical functions of the SASP in OIS might involve a reacti-
vation of developmental processes. Indeed, this common
expression of key mediators and features suggests that senes-
cence might primarily have arisen as a developmental mecha-
nism that was later adapted during evolution to perform its
adult roles.
However, there are also notable differences between develop-
mental and adult senescence. Surprisingly, in senescent cells in
the embryo, we failed to detect p16 or DNA damage, two central
mediators of replicative and oncogene-induced senescence
(Kuilman et al., 2010). Additionally, mediators of senescent rein-
forcement such as interleukin-6 (IL-6) and IL-8 were also notCell 155, 1119–1130, Noincreased in our array (Acosta et al.,
2008; Kuilman et al., 2008). One possible
interpretation is that developmental
senescence represents a more primitive
form of senescence intended as a tempo-
rary signaling process during particular
developmental stages, whereas the path-
ological aspects of OIS or aging necessi-
tated the establishment of more complex
regulation, requiring additional mediators
of reinforcement (Kuilman et al., 2010).
More detailed comparisons of senes-
cence in each condition will be infor-
mative in classifying stimulus-specific
mediators, as well as identifying new
common markers of senescence.
While we, and the accompanying study
(Mun˜oz-Espı´n et al., 2013), identify p21 as
one mediator of developmental senes-
cence, precisely how p21 contributes tothe regulation of developmental senescence remains to be
determined. A member of the CIP/KIP family of cyclin-depen-
dent kinase inhibitors, p21 is a potent inhibitor of proliferation
and an important mediator of senescence (Xiong et al., 1993).
Despite primarily being regulated by p53 in stress-induced
senescence, in the embryo, p21 function is p53 independent
(Parker et al., 1995). However, an additional feature of p21 is to
protect from apoptosis, both at the intracellular level and through
paracrine effects mediated by the secretion of survival/SASP
factors (Chang et al., 2000; Devgan et al., 2006; Roninson,
2002). Our data suggest that p21 contributes to many aspects
of the senescent state, preventing proliferation and apoptosis,
while regulating secretion of SASP factors. Interestingly, how-
ever, in OIS, p21 levels are not maintained and return to nearly
normal levels as p16 increases to establish irreversibility (Alcorta
et al., 1996). As loss of p21 is associated with apoptosis in the
limb mesenchyme (Vasey et al., 2011 and data not shown), this
suggests that the p21-p16 expression juncture might representvember 21, 2013 ª2013 Elsevier Inc. 1127
a critical step in the senescence-apoptosis fate determination of
cells.
Additionally, it might seem surprising that mice deficient in p21
do not havemore pronounced developmental defects. However,
embryos are particularly resilient and adaptive to alterations,
often requiring compound deficiencies before a frank defect
manifests, as in the case of the pRB-related p130 and p107
genes (Cobrinik et al., 1996) or FGFmembers in the AER (Mariani
et al., 2008). Alternatively, adaptations can arise, as seen in mice
deficient in the proapoptotic mediator Apaf1, which present with
a delayed mid-stage limb development that is ultimately
resolved by birth (Yoshida et al., 1998). Furthermore, whereas
a deficiency of the hematopoietic lineage-specific transcription
factor PU.1 prevents macrophage development, clearance of
interdigital cell death is functionally replaced by mesenchymal
cells adopting phagocytic properties (Wood et al., 2000). In the
absence of p21, it is possible that other family members such
as p57 or senescence mediators like p15 might play similar
compensatory roles (Zhang et al., 1999).
Our study shows that, at least in the AER, senescent cells
undergo a fate of cell death and immune-mediated clearance.
The role of apoptosis and macrophage-mediated phagocytosis
in interdigital cell death is well established, as is the immune-
mediated clearance of adult senescence (Kang et al., 2011;
Wood et al., 2000; Xue et al., 2007). However, whether senescent
cells in the limb undergo apoptosis before clearance or macro-
phages directly induce apoptosis in the senescent cells remains
to be shown (Lang and Bishop, 1993). Nonetheless, it is inter-
esting to note that macrophages are recruited to lie adjacent to
the senescent AER prior to the appearance of cell death (Rae
et al., 2007), suggesting that a primary function of senescence
is to contribute to the cellular balance of the tissue, recruiting
macrophages to sites where they will ultimately be needed for
phagocytosis. In addition, as embryonic macrophages can
have trophic and patterning functionsmediated byCSF1 instruc-
tion (Qian and Pollard, 2010; Rae et al., 2007), it is tempting to
speculate that developmental senescence might also indirectly
contribute to tissue patterning.
Notably, this study uncovers the senescence program as an
integral and inseparable component of limb biology, with disrup-
tion of the normal homeostatic signals through genetic or
chemical means, leading to a loss of the senescent state. This
introduces the question of the identity of senescence-inducing
signals. We identify that a disruption of pERK signaling in the
underlyingmesenchymeperturbs normal senescenceanddevel-
opment. Interestingly, Rel/NF-kB, a master regulator of OIS and
the SASP, is expressed in the PZ and is required for proper
AER maintenance, suggesting that this might be one such medi-
ator of senescence instruction from the pERK-positive mesen-
chyme (Kanegae et al., 1998). However, our data also suggest
that the AERmay be subject to autocrine or local-paracrine influ-
ence on the senescent state within the AER, involving CEBP/b,
transforming growth factor b (TGF-b), and p15 pathways (Acosta
et al., 2013; Gomis et al., 2006; Hannon and Beach, 1994).
In summary, this study and the accompanying manuscript
fromSerrano and colleagues (Mun˜oz-Espı´n et al., 2013) describe
the identification of cellular senescence as a cellular process and
an additional layer of regulation in the developing embryo. We1128 Cell 155, 1119–1130, November 21, 2013 ª2013 Elsevier Inc.focused on two main areas where senescence is detected, the
AER and the RP. Interestingly, these are among the most
frequently disrupted areas affected by developmental birth
defects, implying that an investigation of the regulatory mecha-
nisms of developmental senescence might shed new light on
the causes of developmental abnormalities. Additionally, this
discovery helps to reconcile known and paradoxical functions
of senescent cells in the adult with their biological role in the em-
bryo, firmly establishing the importance of cellular senescence
as a distinct regulatory and instructive cellular mechanism.
EXPERIMENTAL PROCEDURES
Animal Use and Genotyping
Mice were housed in accordance with the CEEA (Ethical Committee for Animal
Experimentation) of the Government of Catalonia. The details and genetic
models used are described in the Extended Experimental Procedures.
Fertilized hen’s eggs (Granja Gibert, Tarragona, Spain) were incubated at
38C for specified times, and embryos were staged according to Hamburger
and Hamilton (1992).
Histological Analysis, Immunohistochemistry, and
Immunofluorescence
Embryos were fixed in 4% PFA for 3 hr at room temperature and washed in
PBS, and tissues were processed for paraffin embedding and sectioning.
Embryos for phospho-ERK (p44/42) immunostaining were fixed in EFA
solution overnight at 4C. Immunostaining was performed using standard
procedures with a complete list of antibodies included in the Extended
Experimental Procedures. Whole-mount SAb-gal was detected as previously
described (Keyes et al., 2005). Incubation with X-gal was restricted to 3 hr
unless otherwise stated.
Culture and Infection of Human Lung IMR90 Fibroblasts
IMR90 fibroblast cultures were established and infected with oncogenic-Ras
as per standard procotols. p21 deficiency was achieved through infection of
pooled siRNA constructs against p21 (Thermo Scientific). Sequences are
provided in Table S3.
Microarray Analysis
Individual AER and limb ectoderm was microdissected from E11.5 forelimbs.
Samples from 2–3 mice were pooled for each replicate, for 3–4 replicates.
Total RNA was isolated using an RNA-easy plus micro RNA extraction kit
(QIAGEN). RNA was subsequently labeled and hybridized to Agilent 8x60,
1-color gene expression arrays, with a detailed description of the analysis
and statistical methods in the Extended Experimental Procedures.
RT-qPCR and Real-Time qPCR Analysis
Total RNA from cells and embryonic tissues was purified using an RNA-easy
micro RNA extraction kit (QIAGEN). Equal amounts of RNA were reverse-
transcribed using random hexamer priming and SuperScript III (Invitrogen).
Real time qPCR was performed using gene-specific primers (sequences in
Table S3) and a LightCycler 480 (Roche).
ACCESSION NUMBERS
Data have been deposited in the Gene Expression Omnibus (GEO) database
(http://www.ncbi.nlm.nih.gov/geo/) with accession number GSE51877.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and three tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cell.2013.10.041.
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